AT279802B - Verfahren zur Herstellung von neuen Komplexen mit antitussiver Wirkung - Google Patents

Verfahren zur Herstellung von neuen Komplexen mit antitussiver Wirkung

Info

Publication number
AT279802B
AT279802B AT261667A AT261667A AT279802B AT 279802 B AT279802 B AT 279802B AT 261667 A AT261667 A AT 261667A AT 261667 A AT261667 A AT 261667A AT 279802 B AT279802 B AT 279802B
Authority
AT
Austria
Prior art keywords
preparation
antitussive effect
new complexes
complexes
new
Prior art date
Application number
AT261667A
Other languages
German (de)
English (en)
Original Assignee
Mead Johnson & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson & Co filed Critical Mead Johnson & Co
Application granted granted Critical
Publication of AT279802B publication Critical patent/AT279802B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0036—Galactans; Derivatives thereof
    • C08B37/0042—Carragenan or carragen, i.e. D-galactose and 3,6-anhydro-D-galactose, both partially sulfated, e.g. from red algae Chondrus crispus or Gigantia stellata; kappa-Carragenan; iota-Carragenan; lambda-Carragenan; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04—Salts; Organic complexes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT261667A 1966-03-18 1967-03-17 Verfahren zur Herstellung von neuen Komplexen mit antitussiver Wirkung AT279802B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR54024A FR5227M (enEXAMPLES) 1966-03-18 1966-03-18

Publications (1)

Publication Number Publication Date
AT279802B true AT279802B (de) 1970-03-25

Family

ID=8604122

Family Applications (1)

Application Number Title Priority Date Filing Date
AT261667A AT279802B (de) 1966-03-18 1967-03-17 Verfahren zur Herstellung von neuen Komplexen mit antitussiver Wirkung

Country Status (6)

Country Link
AT (1) AT279802B (enEXAMPLES)
BE (1) BE695604A (enEXAMPLES)
DK (1) DK115144B (enEXAMPLES)
FR (1) FR5227M (enEXAMPLES)
GB (1) GB1183403A (enEXAMPLES)
NL (1) NL6704037A (enEXAMPLES)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0139881A1 (en) * 1983-09-16 1985-05-08 Pennwalt Corporation Liquid prolonged release pharmaceutical formulations containing ionic constituents
US4762709A (en) * 1983-09-16 1988-08-09 Pennwalt Corporation Liquid prolonged release pharmaceutical formulations containing ionic constituents

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK171716B1 (da) * 1982-03-12 1997-04-07 Pharmacia & Upjohn Ab Fremgangsmåde til fremstilling af et kompleks af carrageenan og emepronium, doxycyklin eller propranolol
US4898860A (en) * 1985-08-16 1990-02-06 New York University Anticonvulsant composition and method
US4694010A (en) * 1985-08-16 1987-09-15 New York University Anticonvulsant compositions and method
FR2640137A1 (fr) * 1988-12-08 1990-06-15 Texinfine Sa Systemes transporteurs de principes actifs lipophiles et leur procede d'obtention
EP0454044B1 (de) * 1990-04-25 1995-12-06 Hoechst Aktiengesellschaft Pharmakologische Zubereitung, enthaltend Polyelektrolytkomplexe in mikropartikulärer Form und mindestens einen Wirkstoff
IT1297461B1 (it) 1997-10-29 1999-12-17 Ciocca Maurizio Preparazione di compresse a rilascio controllato a base di complessi tra carragenano e farmaci basici solubili
US7101575B2 (en) 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
DE102004013637A1 (de) 2004-03-19 2005-10-13 Capsulution Nanoscience Ag Verfahren zur Herstellung von CS-Partikeln und Mikrokapseln unter Verwendung poröser Template sowie CS-Partikel und Mikrokapseln
FR2906687A1 (fr) * 2006-10-10 2008-04-11 Pierre Calleja Substrat pour la conservation et la distribution d'ingredients actifs pour animaux aquatiques

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0139881A1 (en) * 1983-09-16 1985-05-08 Pennwalt Corporation Liquid prolonged release pharmaceutical formulations containing ionic constituents
US4762709A (en) * 1983-09-16 1988-08-09 Pennwalt Corporation Liquid prolonged release pharmaceutical formulations containing ionic constituents

Also Published As

Publication number Publication date
BE695604A (enEXAMPLES) 1967-09-18
NL6704037A (enEXAMPLES) 1967-09-19
GB1183403A (en) 1970-03-04
FR5227M (enEXAMPLES) 1967-08-14
DK115144B (da) 1969-09-08

Similar Documents

Publication Publication Date Title
AT280996B (de) Verfahren zur Herstellung von neuen 1-Hydroxyphenyl-2-aminoalkanolen
CH490319A (de) Verfahren zur Herstellung von neuen Amino-dihalogen-phenyläthylaminen
CH484049A (de) Verfahren zur Herstellung von neuen Hydroxycyclohexylaminen
AT272343B (de) Verfahren zur Herstellung von neuen 2-Cycloalkylamino-oxazolinen
AT267538B (de) Verfahren zur Herstellung von neuen Carbostyrilderivaten
AT279802B (de) Verfahren zur Herstellung von neuen Komplexen mit antitussiver Wirkung
AT275517B (de) Verfahren zur Herstellung von neuen p-Alkoxy-piperidin-amiden
CH498130A (de) Verfahren zur Herstellung von neuen Pyridyl-tetrahydroisochinolinen
AT261633B (de) Verfahren zur Herstellung von neuen Organozinnkomplexen
CH487887A (de) Verfahren zur Herstellung von neuen 1-Aryl-3-alkylaminopyrrolidinen
AT272369B (de) Verfahren zur Herstellung von neuen 6-Amino-uracil-5-carbonamid-N-sulfonamiden
AT291221B (de) Verfahren zur Herstellung von neuen o-Carboxyphenylamidinen
CH482727A (de) Verfahren zur Herstellung von neuen Phosphinylimiden
AT270653B (de) Verfahren zur Herstellung von neuen 5-Benzylpyrimidinen
AT267713B (de) Verfahren zur Herstellung von neuen Aminodiphenyl-indolyl-methanfarbstoffen
AT283319B (de) Verfahren zur Herstellung von neuen Azidozimtaldehyden
AT281797B (de) Verfahren zur Herstellung von neuen Dialkylaminoacylaniliden
AT277186B (de) Verfahren zur Herstellung von neuen Trihalogenäthylglycinaten
CH487114A (de) Verfahren zur Herstellung von neuen 1-Amino-3-aryloxypropan-2-äthern
CH497411A (de) Verfahren zur Herstellung von neuen Homogonan-Derivaten
AT290022B (de) Verfahren zur Herstellung von neuen 16-Methyl-4-pregnen-3β-ol-20-onen
AT287676B (de) Verfahren zur herstellung von neuen 1-phenoxy-2-aminoalkanen
AT274779B (de) Verfahren zur Herstellung von neuen 1-Hydrazinoadamantanen
CH507223A (de) Verfahren zur Herstellung von neuen 17-Phenyloxyacetyloxysteroiden
AT266141B (de) Verfahren zur Herstellung von neuen Haxahydropyrimidinderivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee